Dr Lal PathLabs, Metropolis, other diagnostic stocks fall up to 3% after Amazon launches home testing service
home diagnostics
services across six major cities.
Dr Lal PathLabs
and
Metropolis
fell up to 3% in early trade.
Krsnaa Diagnostics
slipped 2.2%,
Thyrocare Technologies
was down nearly 1%, and
Suraksha Diagnostic
dipped 0.5% on the BSE.
The pressure followed Amazon India's announcement on Sunday about the rollout of
Amazon Diagnostics
, an at-home
lab testing service
that allows users to book tests, schedule and track sample collection, and access digital reports via the Amazon app.
The service, in collaboration with
Orange Health
Labs, will be available in Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad, covering over 450 PIN codes.
Also Read:
Why stock market is falling today? Key factors behind 900-point Sensex crash, Nifty below 24,850
Amazon has integrated this new offering with its existing health services — Amazon Pharmacy and Amazon Clinic — under the Amazon Medical banner.
"This expansion strengthens the foundation of Amazon Medical by building on the existing service of Pharmacy and Clinic. With Amazon Pharmacy, customers get access to a wide range of prescription medications and healthcare essentials, along with a free telemedicine consultation service and delivery benefits for Prime and non-Prime members. Amazon Clinic enables customers to consult licensed doctors for a range of primary healthcare needs through a seamless digital experience," Amazon said.
Amazon Diagnostics will offer over 800 diagnostic tests and doorstep sample collection within 60 minutes.
Also Read:
Is the grey market premium misleading? Decoding the valuation gap in HDB Financial's IPO
The tech giant's entry into diagnostics adds competition for established players, triggering investor concerns and weighing on stock prices.
Also Read:
11 Nifty mid & smallcap stocks that can rally 40-90% over the next 12 months
(
Disclaimer
: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
31 minutes ago
- Business Standard
Ceat Q1 FY26 results: Profit falls 27% to ₹112 crore, revenue up 10.5%
Ceat on Thursday reported a consolidated net profit of ₹112.45 crore for Q1 FY26, down 27 per cent year-on-year (y-o-y) from ₹154.16 crore in Q1 FY25. However, the tyre maker's profit improved sequentially from ₹99.49 crore in Q4 FY25, according to a BSE filing by the company. The company's revenue for the quarter increased to ₹3,529.41 crore, up 10.5 per cent y-o-y from ₹3,192.82 crore and 3.2 per cent sequentially from ₹3,420.62 crore. On the expenditure end, the company spent ₹3,375.10 crore in the quarter, up 12.4 per cent from ₹3,003.56 crore in the same quarter last year. Sequentially, the expenses increased 3.6 per cent from ₹3,259.26 crore. Commenting on the quarter performance, Arnab Banerjee, managing director and chief executive officer at Ceat, said, 'We continue to grow at a strong pace with double-digit growth in top-line, driven by OEM and replacement segments. Looking ahead, we are well poised to ride the premiumisation and electrification trend in the domestic market, and renew our growth in international markets with stability in the geopolitical situation.' The company also announced the re-appointment of Banerjee for a further term of two years, starting April 1, 2026. Adding to it, Chief Financial Officer Kumar Subbiah said that the revenue growth came on the back of an increase in demand from original equipment manufacturers (OEM) and replacement segments. "As Q1 is a marketing-heavy quarter with significant marketing costs associated with IPL, operational margins saw a slight dip. Efficient cash flow management helped in gross debt coming down by ₹100 crore during the quarter," Subbiah said. Ceat plans ₹450 crore capex for plant expansion Separately, the company proposed a capital expenditure of ₹450 crore to expand capacity at its Chennai plant by around 35 per cent in the passenger car and utility vehicle (PCUV) segment. The expansion, expected to be completed by the end of FY 2027, will be funded through a mix of internal accruals and debt, according to the BSE filing.
News18
32 minutes ago
- News18
Jeff Bezos-Lauren Sanchez: Should Regular, Not-So-Rich Indian Couples Sign A Prenup?
Last Updated: Jeff Bezos-Lauren Sanchez wedding: Can regular couples sign prenups? What can the terms be? Would it put non-earning spouse at a disadvantage? Is it legally valid in India? Jeff Bezos-Lauren Sanchez wedding: As the details and pictures of the lavish celebrations of Amazon founder Jeff Bezos to his fiancée Lauren Sánchez in Venice come out, there's also the buzz of a ' prenuptial agreement or prenup" around it. The couple reportedly married in the US weeks before their lavish $10 million (approximately Rs 388-460 crore) wedding celebration in Venice on June 26, featuring a star-studded guest list. While Bezos and Sanchez may or may not have chosen to sign a prenuptial agreement, it is a crucial document which details what each person will take away in terms of assets, debts and spousal support should the marriage end in divorce or death. Bezos — the founder of Amazon whose net worth Forbes estimates to be north of $200 billion — has a lot of wealth to protect, should his second marriage go south. But chances are his assets and estate are already structured and professionally managed in a way that they would never become marital assets, two attorneys who specialise in prenups told CNN. The curiosity is only around the payout she would get if they divorced or he predeceases her, in case they signed a prenup. But for everyone else wondering if they should get a prenup before saying 'I do," there are many factors to consider for both partners. Do regular couples sign prenups? For one, the stigma around prenups as a sign that at least one partner doesn't trust the incoming spouse or is worried the marriage wouldn't last has gone. CNN, in a special piece on prenups, noted the changing trend. Illinois-based divorce and marital attorney Gail O'Connor, founder of O'Connor Family Law, told CNN she has seen a huge jump in couples seeking them out. 'Millennials want to be very financially independent. So there is this idea of people getting married later and thinking, 'I've worked hard for this and want to protect it,'" O'Connor said. But the 'it" doesn't have to mean billions or even millions. It could just mean you've worked for a decade and built up savings, investments and stock options. Or, conversely, she said she has seen a lot of couples where one person has a large debt load — for example, $100,000 or more in education loans. 'And their partner wants to be protected from that," O'Connor said. Why do prenups matter and to whom? Prenups are most critical where one partner owns a business. 'It's not about the actual level of wealth but what the assets are when a couple marries," Jacqueline Newman, managing partner of Berkman Bottger Newman & Schein in New York told CNN. While a business may not be worth much at the time of wedding, it might grow greatly during the marriage, which also happened in case of Bezos during his first marriage to MacKenzie Scott. Prenups also matter to: What can regular couples include in a prenup? Whatever you want. Newman said a regular couple can opt for a prenup that: Asserts that any assets or debt in one person's name goes with that person at the end of the marriage. Any assets or debts in both partners' names are split. A simple prenup might also just focus on a single asset and how it will be treated if the marriage dissolves. Could address the issue of how one partner's debt is paid off during the marriage. For instance, if any jointly held marital assets are used to make one partner's debt payments, that partner may need to reimburse the joint account. What would couples need to get a prenup? Financial disclosures O'Connor told CNN she asks her clients to give her proof of their assertions by way of their most recent tax returns, W2s, stock option grants, business valuations, and bank and brokerage statements. 'You don't want to build a contract subject to a successful attack. The more disclosure you have, the better," she said. Prenups in India prenuptial agreements to understand the intentions of the parties involved during divorce proceedings, particularly in cases where there is a dispute over financial matters. While states like Goa recognise such contracts under the Portuguese Civil Code, the rest of India views marriage predominantly through the lens of personal laws. The Hindu Marriage Act views marriage as a sacrament rather than a contract. The nikahnama (a prenuptial agreement in Islamic law) is an exception, as it is recognised as a part of Muslim marriage and can be considered valid if it complies with Islamic law and doesn't contradict it. Other options for Indian couples Couples may explore other options like creating family trusts or trusts for each family member to manage assets and provide some level of financial security. Some lawyers draft 'quasi-prenuptial" or 'postnuptial" agreements, which are not legally binding but can be used to record the couple's understanding on various financial and other matters, potentially influencing court decisions or preventing false claims. According to the Indian Contract Act, 1872, a valid contract requires consideration, something of value exchanged between parties. As prenups typically involve no such exchange before marriage, they are often deemed unenforceable. However, there are exceptions where courts have upheld these agreements when they focus on property distribution rather than marital dissolution. It also helps in terms of alimony or maintenance discussion if the marriage is dissolved. With CNN, Agencies Inputs About the Author Manjiri Joshi At the news desk for 17 years, the story of her life has revolved around finding pun, facts while reporting, on radio, heading a daily newspaper desk, teaching mass media students to now editing special copies ...Read More Get Latest Updates on Movies, Breaking News On India, World, Live Cricket Scores, And Stock Market Updates. Also Download the News18 App to stay updated! tags : Jeff Bezos Lauren Sanchez view comments Location : New Delhi, India, India First Published: June 27, 2025, 13:29 IST News explainers Jeff Bezos-Lauren Sanchez: Should Regular, Not-So-Rich Indian Couples Sign A Prenup? Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
an hour ago
- News18
Anthem Biosciences IPO Subscribed 77% On Day 1: Apply Or Not? Check Price, GMP, Review
Last Updated: The GMP of the Anthem Biosciences IPO currently stands at 17.54%, indicating strong listing gains. Should I Subscribe To Anthem Biosciences IPO? The initial public offering of Anthem Biosciences Ltd opened today, Monday, July 14. The price band of the mainboard IPO, which aims to raise Rs 3,395 crore, has been fixed in the range of Rs 540 to Rs 570. On the first day of bidding on Monday, the issue received a 0.77 times subscription, garnering bids for 3,22,28,066 shares as against the 4,17,50,321 shares on offer. The retail and NII participation stood at 0.62x and 1.64x, respectively. The QIB category received a 0.39x subscription. The IPO's grey market premium currently stands at 17.54%, indicating strong listing gains. The three-day IPO will be closed on July 16. Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises in fermentation-based active pharmaceutical ingredients (APIs) for global pharma and biotech clients. Anthem Biosciences IPO GMP Today According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 670 against its upper IPO price of Rs 570. It means a grey market premium or GMP of Rs 100, which is 17.54% over its issue price, indicating strong listing. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. The price band of the IPO has been fixed in the range of Rs 540 to Rs 570 apiece. Its minimum lot size is 26. It means investors will have to apply for a minimum of 26 shares or in multiple thereof. Retail investors require a minimum capital of Rs 14,040 to apply for the IPO. Anthem Biosciences IPO Allotment And Listing Dates The basis of allotment of the Anthem Biosciences IPO will be finalised on July 17. Its shares will be listed on both BSE and NSE, July 21. Anthem Biosciences IPO: Should You Apply? Brokerages remain largely optimistic about Anthem Biosciences' initial public offering, citing its strong financial track record, niche positioning in the CRDMO space, and robust pipeline. However, a few have flagged concerns over valuations and margin pressures. Aditya Birla Money has recommended a 'subscribe' rating, emphasising the company's leadership team, molecule pipeline, and strategic capacity expansion. 'Anthem's customer profile and molecule pipeline provide long-term demand visibility reinforced by strategic capacity expansion." However, it cautioned that growth is dependent on the success of pipeline molecules and regulatory compliance, among other risks. Anand Rathi Shares & Stock Broking noted that Anthem is 'positioned to cater in CROs and CRDMO segment — the crucial players in the pharma and biotechnology industries — wherein it is being niche player with high entry barriers through its differentiated FFS model, long-term relationship, strong R&D, innovation and technology-driven approach." The brokerage firm added that the company has outperformed peers in profitability and is likely to maintain that edge, assigning a 'subscribe' rating. SBI Securities echoed the sentiment, highlighting that the IPO is valued at a P/E of 70.9x FY25 earnings and appears fairly priced compared to peers. It said, 'It is well placed to encash on the fast-growing CRDMO industry on the back of capacity expansion plans and funding in place; well established track record of profitable growth; and strong business pipeline." Canara Bank Securities offered a 'subscribe for long term' recommendation, citing a strong CAGR of 32% in revenue and 8% in PAT between FY23 and FY25. It emphasised Anthem's FFS model and ESG initiatives, saying, 'The issue is fairly priced, which is at a discount of its listed peers." SMIFS pointed to the doubling of capacity and deeper penetration into regulated markets as key growth drivers. 'The doubling of capacities in the first phase of capex and then another round of capex will propel the company into the league of the largest fermentation players in India," it noted while recommending a long-term subscribe. Ventura Securities was bullish on the sectoral opportunity, stating that 'Anthem Biosciences is exceptionally positioned to capitalize on the fast-growing global CRDMO market, projected to expand at a CAGR of 9.1% from $213.1 billion in 2024 to $330 billion by 2029." It also highlighted Anthem's 95.59% FFS contract success rate and regulatory certifications from USFDA, ANVISA, and ISO. Swastika Investmart pointed out the company's high valuation but justified it due to Anthem's fermentation capacity and global clientele. 'Well-positioned in a high-growth sector with robust financials and global client relationships… subscribe for the listing gains and long term," it advised. Recommending investors to 'Subscribe' for long term, Mehta Equities research analyst Rajan Shinde said, 'We believe the Anthem Biosciences IPO brings investors an opportunity to invest in the high-growth CRDMO space, uniquely positioned with fully integrated capabilities across small and large molecules, including NCE and NBE platforms — a rarity in India. We think with a strong track record of over 8,000 projects, deep engagement with more than 675 clients, and a robust pipeline of 242 active projects, Anthem has demonstrated sustained innovation through early adoption of advanced modalities like ADC, RNAi, and flow chemistry, and a leadership position in green chemistry." The IPO is entirely an offer-for-sale (OFS). So, the company will not receive any funds from the issue and the proceeds will go to the selling shareholders. Anthem Biosciences raised Rs 1,016 crore from anchor investors ahead of its initial share-sale opening for public subscription. Some of the investors that participated in the anchor book are — Abu Dhabi Investment Authority, Government Pension Fund Global, Eastspring Investments, Amundi Funds, PineBridge Global Funds and Societe Generale, HDFC MF (MF), ICICI Prudential MF, Axis MF, UTI MF, Quant MF and Motilal Oswal MF. Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It also manufactures and sells complex specialized fermentation-based Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars. Sai Life Sciences Ltd, Syngene International, Suven Life Sciences and Divi's Laboratories are the listed peers of Anthem Biosciences. JM Financial, Citigroup Global Markets India, J P Morgan India and Nomura Financial Advisory and Securities (India) are the book-running lead managers for the issue. Stay updated with all the latest business news, including market trends, stock updates, tax, IPO, banking finance, real estate, savings and investments. Get in-depth analysis, expert opinions, and real-time updates—only on News18. Also Download the News18 App to stay updated! tags : initial public offering (IPO) IPO view comments Location : New Delhi, India, India First Published: July 14, 2025, 11:35 IST News business » ipo Anthem Biosciences IPO Subscribed 77% On Day 1: Apply Or Not? Check Price, GMP, Review Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
